Last reviewed · How we verify

NCT03426215

Long-Term Course of Korean Medicine Treatment for Lumbar Disc Herniation

Completed Last updated 4 June 2018
What this trial tests

trial testing Magnetic Resonance Imaging (MRI) in Low Back Pain in 65 participants. Completed in 28 April 2018.

Timeline
10 March 2018
Primary endpoint
28 April 2018
28 April 2018

Quick facts

Lead sponsorJaseng Medical Foundation
StatusCompleted
Study typeOBSERVATIONAL
Enrollment65
Start date10 March 2018
Primary completion28 April 2018
Estimated completion28 April 2018
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Jaseng Medical Foundation

Who can join

Eligibility, any sex, with Low Back Pain or Sciatica. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study will assess the long-term course and effect of Korean medicine treatment in lumbar intervertebral disc herniation patients who received integrative Korean medicine treatment for 24 weeks as part of a previous clinical study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pain, disability, and MRI changes in lumbar disc herniation patients treated with integrative medicine: Ten-year results of an observational study.
    Lee J, Ha IH, Kim MR, Cho HW, et al · · 2022 · cited 3× · PMID 35059291 · DOI 10.1016/j.imr.2022.100833

Verify or expand the search:

Other trials of Magnetic Resonance Imaging (MRI)

Trials testing the same drug.

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Jaseng Medical Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03426215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing